Neuroprotection against ischemia by metabolic inhibition revisited: A comparison of hypothermia, a pharmacologic cocktail and magnesium plus mexiletine

Annals of the New York Academy of Sciences

Volumn 890, Issue , 1999, Pages 240-254

  Maynard, Kenneth I ^a   Quiñones Hinojosa, Alfredo ^a   Malek, Junaid Y ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINO 4 PHOSPHONOBUTYRIC ACID; 2 AMINO 5 PHOSPHONOVALERIC ACID; AMILORIDE; GLUCOSE; LACTIC ACID; LITHIUM; MAGNESIUM; MEXILETINE; OXYGEN; TETRODOTOXIN;

ACTION POTENTIAL; ANIMAL TISSUE; CONFERENCE PAPER; CONTROLLED STUDY; DRUG MIXTURE; ELECTROPHYSIOLOGY; ENERGY METABOLISM; GLUCOSE UTILIZATION; INDUCED HYPOTHERMIA; ISCHEMIA; METABOLIC INHIBITION; NEUROPROTECTION; NONHUMAN; RABBIT; REGRESSION ANALYSIS; RETINA;

ANIMALIA; ORYCTOLAGUS CUNICULUS;

EID: 0033379225     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1999.tb07999.x     Document Type: Conference Paper

References (67)

1. 1. Siesjö, B.K. 1992. Pathophysiology and treatment of focal cerebral ischemia. Part I: Pathophysiology. J. Neurosurg. 77: 169-184.
2. 2. Café, C., C. Torri & F. Marzatico. 1993. Cellular and molecular events of ischemic brain damage. Funct. Neurol. 8: 121-133.
3. 3. Martin, R.L., H.G.E. Lloyd & A.I. Cowan. 1994. The early events of oxygen and glucose deprivation: setting the scene for neuronal death? Trends Neurosci. 17: 251-257.
4. 4. W. Pulsinelli. 1995. The ischemic penumbra in stroke. Sci. Am. Sci. Med. Jan/Feb: 16-25.
5. 5. Calabresi, P., G.A. Marfia, D. Centonze et al. 1999. Sodium influx plays a major role in the membrane depolarization induced by oxygen and glucose deprivation in rat striatal spiny neurons. Stroke 30: 171-179.
6. 6. Obrenovitch, T.P. & J. Urenjak. 1997. Altered glutamatergic transmission in neurological disorders: from high extracellular glutamate to excessive synaplic efficacy. Prog. Neurobiol. 51: 39-87.
7. 7. Sweeney, M.I. 1997. Neuroprotective effects of adenosine in cerebral ischemia: window of opportunity. Neurosci. Biobehav. Rev. 21: 207-217.
8. 8. Kristian, T. & B.K. Siesjö. 1998. Calcium in ischemic cell death. Stroke 29: 705-718.
9. 9. Vornov, J.J., A.G. Thomas & D. Jo. 1996. Protective effects of extracellular acidosis and blockade of sodium/hydrogen ion exchange during recovery from metabolic inhibition in neuronal tissue culture. J. Neurochem. 67: 2379-2389.
10. 10. Hall, E.D. 1997. Brain attack: acute therapeutic interventions. Free radical scavengers and antioxidants. Neurosurg. Clin. North Am. 8: 195-206.
11. 11. Iadecola, C. 1997. Bright and dark sides of nitric oxide in ischemic brain injury. Trends Neurosci. 20: 132-139.
12. 12. Massa, S.M., R.A. Swanson & F.R. Sharp. 1996. The stress gene response in brain. Cerebrovasc. Brain Metab. Rev. 8: 95-158.
13. 13. MacManus, J.P. & M.D. Linnik. 1997. Gene expression induced by cerebral ischemia: an apoptotic perspective. J. Cereb. Blood Flow Metab. 17: 815-832.
14. 14. Ginsberg, M.D. 1993. Emerging strategies for the treatment of ischemic brain injury. In Molecular and Cellular Approaches to the Treatment of Neurological Diseases. S.G. Waxman, Ed.: 207-237. Raven Press, Ltd. New York.
15. 15. Grotta, J. 1994. The current status of neuronal protective therapy: why have all neuronal protective drugs worked in animals but none so far in stroke patients? Cerebrovasc. Dis. 4: 115-120.
16. 16. Muir, K.W. & K.R. Lees. 1995. Clinical experience with excitatory amino acid antagonist drugs. Stroke 26: 503-513.
17. 17. Barinaga, M. 1996. Finding new drugs to treat stroke. Science 272: 664-666.
18. 18. Fisher, M. 1997. Characterizing the target of acute stroke therapy. Stroke 28: 866-872.
19. 19. Quiñones-Hinojosa, A., C.S. Ogilvy & K.I. Maynard. 1998. Hypothermia during ischemia improves recovery of neuronal metabolism and function in the in vitro retina [abstract]. Soc. Neurosci. Abstr. 24: 1506.
20. 20. Ames III, A., K.I. Maynard, & S. Kaplan. 1995. Protection against CNS ischemia by temporary interruption of function-related processes of neurons. J. Cereb. Blood Flow Metab. 15: 433-439.
21. 21. Maynard, K.I., T. Kawamata, C.S. Ogilvy et al. 1998. Avoiding stroke during cerebral arterial occlusion by temporarily blocking neuronal functions in the rabbit. J. Stroke Cerebrovasc. Dis. 7: 287-295.
22. 22. Maynard, K.I., A. Quiñones & C.S. Ogilvy. 1998. Magnesium plus mexiletine inhibit energy usage and protect retinas against ischemia. NeuroReport 9: 4141-4144.
23. 1H magnetic resonance spectroscopy. Pediatr. Res. 38: 919-925.
24. 31P nuclear magnetic resonance study in unanesthetized neonatal rats. Pediatr. Res. 42: 700-708.
25. 25. Yager, J.Y. & J. Asselin. 1996. Effect of mild hypothermia on cerebral energy metabolism during the evolution of hypoxic-ischemic brain damage in the immature rat. Stroke 27: 919-925.
26. 26. Zager, E.L. & A. Ames III, 1988. Reduction of cellular energy requirements: screening for agents that may protect against CNS ischemia. J. Neurosurg, 69: 568-579.
27. 27. Dong, L.P., T.Y. Wang & L. Zhang. 1992. Effect of mexiletine on energy metabolism of ischemic brain. Acta Pharmacol. Sin. 13: 354-356.
28. 28. Barone, F.C., G.Z. Feuerstein & R.F. White. 1997. Brain cooling during transient focal ischemia provides complete neuroprotection Neurosci. Biobehav. Rev. 21: 31-44.
29. 29. Kochs, E. & C. Werner. 1995. Neuroprotection: fact or fantasy? Eur. J. Anaesthesiol. Suppl. 10: 67-70.
30. 30. Colbourne, F., G. Sutherland & D. Corbett. 1997. Postischemic hypothermia: a critical appraisal with implications for clinical treatment. Mol. Neurobiol. 14: 171-201.
31. ++ protect against irreversible damage during CNS ischemia. Stroke 15: 695-698.
32. 32. Marinov, M.B., K.S. Harbaugh, P.J. Hoopes et al. 1996. Neuroprotective effects of preischemia intraarterial magnesium sulfate in reversible focal cerebral ischemia. J. Neurosurg. 85: 117-124.
33. 33. Zhang, X.S. & T.Y. Wang. 1993. Protection of mexiletine against hypoxic damage of synaptic function in hippocampal slices. Acta Pharmacol. Sin. 14: 426-429.
34. 34. Stys, P.K. & H. Lesiuk. 1996. Correlation between electrophysiological effect of mexiletine and ischemic protection in central nervous system white matter. Neuroscience 71: 27-36.
35. 35. Maynard, K.I., D. Chen, P.M. Arango et al. 1996. Nitro-L-arginine worsens and L-arginine improves functional recovery when added during ischemia in the in vitro rabbit retina. NeuroReport 8: 81-85.
36. 36. Maynard, K.L, P.M. Arango, D. Chen et al. 1998. Acetylsalicylate administered during simulated ischemia impairs the recovery of neuronal function in the in vitro rabbit retina. Neurosci. Lett. 249: 159-162.
37. 37. Malek, J.Y., A. Quiñones-Hinojosa, C.S. OGILVY et al. 1998. An in vitro retina model to study neuronal function and metabolism following ischemia [abstract]. Soc. Neurosci. Abstr. 24: 982.
38. 38. Ames III, A. & R.H. Masland. 1990. The rabbit retina in vitro. In Preparation of Vertebrate Central Nervous System In Vitro. H. Jahnsen, Ed.: 183-202. John Wiley & Sons, Ltd. New York.
39. 39. Astrup, J. 1982. Energy-requiring cell functions in the ischemia brain. Neurosurgery 56: 482-497.
40. 40. Hochachka, P.W. 1986. Defence strategies against hypoxia and hypothermia. Science 231: 234-241.
41. 41. Michenfelder, J.D. & R.A. Treye. 1973. The effects of anesthesia and hypothermia on canine cerebral ATP and lactate during anoxia produced by decapitation. Anesthesiology 33: 430-439.
42. 42. Wright, R.L. & A. Ames III. 1964. Measurement of maximal permissible cerebral ischemia and a study of its pharmacologic prolongation. J. Neurosurg. 21: 567-574.
43. 43. Lo, E.H. & G.K. Steinberg. 1992. Effects of hypothermia on evoked potentials, magnetic resonance imaging, and blood flow in focal ischemia in rabbits. Stroke 23: 889-893.
44. 44. Buchan, A. & W.A. Pulsinelli. 1990. Hypothermia but not the N-methyl-D-aspartate antagonist, MK801, attenuates neuronal damage in gerbils subjected to transient global ischemia. J. Neurosci. 10: 311-316.
45. 45. Busto, R, W.D. Dietrich, M. Globus et al. 1987. Small differences in intraischemic brain temperature critically determine the extent of ischemic neuronal injury. J. Cereb. Blood Flow Metab. 7: 729-738.
46. 46. Field II, J., F.A. Fuhrman & A.W. Martin. 1944. Effects of temperature on the oxygen consumption of brain tissue. J. Neurophysiol. 7: 117-126.
47. 47. Lust, W.D., A.B. Wheaton, G. Feussner et al. 1989. Metabolism in the hamster brain during hibernation and arousal. Brain Res. 489: 12-20.
48. 48. Ridenour, T.R., D.S. Warner, M.M. Todd et al. 1992. Mild hypothermia reduces infarct size resulting from temporary but not permanent focal ischemia in rats. Stroke 23: 733-738.
49. 49. Xue, D., Z.-G. Huang, K.E. Smith et al. 1992. Immediate or delayed mild hypothermia prevents focal cerebral infarction. Brain Res. 587: 66-72.
50. 50. Zeevalk, G.D. & W.J. Nicklas. 1996. Hypothermia and metabolic stress: narrowing the cellular site of early neuroprotection. J. Pharmacol. Exp. Ther. 279: 332-339.
51. 51. Edwards, A.D. & H. Mehmet. 1996. Apoptosis in perinatal hypoxic-ischaemic cerebral damage. Neuropathol. Appl. Neurobiol. 22: 494-498.
52. 52. Shimizu, H., L.H. Chang, L. Litt et al. 1997. Effect of brain, body and magnet bore temperatures on energy metabolism during global cerebral ischemia and reperfusion monitored by magnetic resonance spectroscopy in rats. Magn. Reson. Med. 37: 833-839.
53. 53. Bart, R.D., S. Takaoka, R.D. Pearlstein et al. 1998. Interactions between hypothermia and the latency to ischemic depolarization: implications for neuroprotection. Anesthesiology 88: 1266-1273.
54. 54. Nehls, D.G., M.M. Todd, R.F. Spetzler et al. A comparison of the cerebral protective effects of isofluorane and barbiturates during temporary focal ischemia in primates. Anesthesiology 66: 453-464.
55. 55. Theye, R.A. & J.D. Michenfelder. 1968. The effect of halothane on canine cerebral metabolism. Anesthesiology 29: 1107-1112.
56. 56. Sano, T., J.C. Drummond, P.M. Patel et al. 1992. A comparison of the cerebral protective effects of isoflurane and mild hypothermia in a model of incomplete forebrain ischemia in the rat. Anesthesiology 76: 221-228.
57. 57. Astrup, J., P. Moller, P. Sorensen & H. Rahbek Sorensen. 1981. Inhibition of cerebral oxygen and glucose consumption in the dog by hypothermia, pentobarbital and lidocaine. Anesthesiology 55: 263-268.
58. 58. Michenfelder, J.D. 1973. Cerebral protection by thiopental during hypoxia. Anesthesiology 39: 510-517.
59. 59. Nillson, L. & B.K. Siesjö. 1975. The effect of pentobarbitone anaesthesia on blood flow and oxygen consumption in the rat brain. Acta Anaesthesiol. Scand. Suppl. 57: 18-24.
60. 60. Todd, M.M. & D.S. Warner. 1992. A comfortable hypothesis reevaluated: cerebral metabolic depression and brain protection during ischemia. Anesthesiology 76: 161-164.
61. 61. Brodersen, P. & E.O. Joørgensen. 1974. Cerebral blood flow and oxygen uptake, and cerebrospinal fluid biochemistry in severe coma. J. Neurol. Neurosurg. Psychiatry 37: 384-391.
62. 62. Schwab, S., M. Spranger, S. Schwartz & W. Hacke. 1997. Barbiturate coma in severe hemispheric stroke: useful or obsolete? Neurology 48: 1608-1613.
63. 63. Ames III, A. 1992. Energy requirements of CNS cells as related to their function and to their vulnerability to ischemia: a commentary based on studies in retina. Can. J. Physiol. Pharmacol. 70: S158-S164.
64. 64. Gorman, C. 1996. Damage control. Time 148: 31-35.
65. 65. LaManna, J.C. & W.D. Lust. 1997. Nutrient consumption and metabolic perturbations. Neurosurg. Clin. North Am. 8: 145-163.
66. 66. Obrenovitch, T.P. 1998. Neuroprotective strategies: voltage-gated Na-channel down-modulation. Rev. Neurosci. 9: 203-211.
67. 67. Jonas, S. 1995. Prophylactic pharmacologic neuroprotection against focal cerebral ischemia. Ann. N.Y. Acad. Sci. 765: 21-25.